Sandoz Faces Another Suit Over Generic Clarinex

Law360, New York (April 2, 2008, 12:00 AM EDT) -- Pharmaceutical company Sepracor Inc. and the University of Massachusetts have filed suit against Sandoz Inc., claiming the generic-drug maker’s proposed version of allergy treatment Clarinex infringes two of their patents.

Sepracor and UMass filed their complaint against Sandoz on Monday in the U.S. District Court for the District of New Jersey in response to an abbreviated new drug application filed by Sandoz with the U.S. Food and Drug Administration.

In its ANDA, Sandoz sought FDA approval to manufacture and market a generic version of Clarinex products...
To view the full article, register now.